Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
Special Issue "Anticancer Drugs 2021"Meegan, Mary J ; O'Boyle, Niamh MPharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (4), p.479 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
12 |
Material Type: Artigo
|
![]() |
Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acidGodugu, Chandraiah ; Patel, Apurva R ; Doddapaneni, Ravi ; Somagoni, Jaganmohan ; Singh, Mandip Dahiya, RajvirPloS one, 2014-03, Vol.9 (3), p.e89919 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
13 |
Material Type: Artigo
|
![]() |
Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugsQuiros, Steve ; Roos, Wynand Paul ; Kaina, Bernd McCormick, David L.PloS one, 2011-11, Vol.6 (11), p.e27183 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
14 |
Material Type: Artigo
|
![]() |
Editorial for the Special Issue "Advances in the Development of Anticancer Drugs"Fotie, JeanInternational journal of molecular sciences, 2024-01, Vol.25 (1), p.641 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
15 |
Material Type: Artigo
|
![]() |
Antioxidant and chemotherapeutic efficacies of seaweed‐derived phlorotannins in cancer treatment: A review regarding novel anticancer drugsPradhan, Biswajita ; Ki, Jang‐SeuPhytotherapy research, 2023-05, Vol.37 (5), p.2067-2091 [Periódico revisado por pares]Chichester, UK: John Wiley & Sons, LtdTexto completo disponível |
16 |
Material Type: Artigo
|
![]() |
Anticancer drugs: Translational target for checkpoint inhibitorsKingwell, KatieNature reviews. Drug discovery, 2018-12, Vol.17 (12), p.863-863 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
17 |
Material Type: Artigo
|
![]() |
Limonoids from neem (Azadirachta indica A. Juss.) are potential anticancer drug candidatesNagini, Siddavaram ; Palrasu, Manikandan ; Bishayee, AnupamMedicinal research reviews, 2024-03, Vol.44 (2), p.457-496 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
18 |
Material Type: Artigo
|
![]() |
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugsKafita, Doris ; Daka, Victor ; Nkhoma, Panji ; Zulu, Mildred ; Zulu, Ephraim ; Tembo, Rabecca ; Ngwira, Zifa ; Mwaba, Florence ; Sinkala, Musalula ; Munsaka, Sody Palit Deb, SwatiPloS one, 2021-04, Vol.16 (4), p.e0248984-e0248984 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
19 |
Material Type: Artigo
|
![]() |
Development of ROS‐responsive amino acid‐based poly(ester amide) nanoparticle for anticancer drug deliveryXu, Qinghua ; Chu, Chih‐ChangJournal of biomedical materials research. Part A, 2021-04, Vol.109 (4), p.524-537 [Periódico revisado por pares]Hoboken, USA: John Wiley & Sons, IncTexto completo disponível |
20 |
Material Type: Artigo
|
![]() |
Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomesHemati, Mahdie ; Haghiralsadat, Fateme ; Jafary, Farzaneh ; Moosavizadeh, Seyedmohammad ; Moradi, AliInternational journal of nanomedicine, 2019-01, Vol.14, p.6575-6585 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |